Effects of rapid antigen testing for pre-admission COVID-19 screening: a before and after study in the emergency department
- Author:
Hyunwoo LEE
1
;
Moon Hwan KWAK
;
Hyun Kyung PARK
;
Chang Hae PYO
;
Keun Hong PARK
;
Hahn Bom KIM
;
Eun Mi HAM
;
Jin Hyung PARK
;
Dong Sun CHOI
;
Jee Hyeon KIM
;
Soo Bok CHOI
Author Information
1. Department of Emergency Medicine, Seoul Medical Center, Seoul, Korea
- Publication Type:Original Article
- From:Journal of the Korean Society of Emergency Medicine
2025;36(6):221-231
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Objective:As the coronavirus disease 2019 (COVID-19) pandemic has been prolonged, the pre-hospital screening test performed in hospitals has changed from polymerase chain reaction (PCR) to rapid antigen test (RAT). RAT has lower sensitivity than PCR, but a lower cost and shorter test time. In the hospital where this study was conducted, the preadmission COVID-19 test was changed from PCR to RAT on February 24, 2023. This study compared the efficacy of PCR and RAT as the pre-admission COVID-19 test.
Methods:This was a retrospective observational study comparing two periods, 90 days from November 25, 2022 to February 23, 2023, and 90 days from February 28, 2023 to May 29, 2023. Patients hospitalized from the emergency medical center during these two periods were included. Binomial logistic regression was used to compare the emergency department length of stay (ED LOS) between the two groups (PCR vs. RAT). Logistic regression was used to compare the mortality.
Results:Four thousand seven hundred and thirty-eight patients were admitted through the emergency room: 2,202 patients in the PCR group and 2,443 patients in the RAT group. No statistically significant differences in the characteristics and severity were observed between the two groups. The mean ED LOS of PCR 5.07 hours (interquartile range, 3.80-6.75) was longer than RAT 3.65 hours (interquartile range, 2.83-4.68) (P<0.001). Mortality was higher in PCR 8.9% than RAT 6.6% (P=0.005).
Conclusion:The study showed that ED LOS and mortality were reduced when using RAT rather than PCR as a preadmission COVID-19 test.
